A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study

BACKGROUND: Delafloxacin is an intravenous (IV)/oral anionic fluoroquinolone with activity against gram-positive (including methicillin-resistant Staphylococcus aureus [MRSA]), gram-negative, atypical, and anaerobic organisms. It is approved in the United States for acute bacterial skin and skin str...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Riordan, William, McManus, Alison, Teras, Juri, Poromanski, Ivan, Cruz-Saldariagga, Maria, Quintas, Megan, Lawrence, Laura, Liang, ShuJui, Cammarata, Sue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093995/
https://www.ncbi.nlm.nih.gov/pubmed/29518178
http://dx.doi.org/10.1093/cid/ciy165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093995/
https://www.ncbi.nlm.nih.gov/pubmed/29518178
http://dx.doi.org/10.1093/cid/ciy165

Ejemplares similares